CompanyDrug

Fudan Team Presents Ribociclib Phase II Bridging Study Results at ESMO Asia

CompanyDrug

Hansoh’s EGFR Inhibitor Ameile Filed for EMA Review by Partner EQRx

CompanyDrug

Sinocelltech’s SCTV01C Vaccine Included in China’s Emergency Use Program

CompanyDrug

Lynk Pharmaceuticals Doses First Patient in Phase II Study for LNK01003

CompanyDeals

Lavamed Secures USD 40M in Angel and Series A Financing Rounds

CompanyDrug

Innovent Biologics Doses First Volunteer in Orismilast Phase I Study

CompanyDrug

Daiichi Sankyo Doses First Patient in Global Phase III TROPION-Lung08 Study

CompanyDeals

Tsingke Biotech Secures RMB 400M Series B Financing for Expansion

CompanyDeals

China Medical System Licenses Opzelura from Incyte for Greater China and Southeast Asia

CompanyDeals

SAFE Raises RMB 500M in Series D Financing to Expand CRO Services

CompanyMedical Device

Peijia Medical Enrolls First Patient in GeminiOne TEER System Study

CompanyDrug

NMPA Approves Henlius’ HLX04 Biosimilar for Lung and Colorectal Cancer